Impel NeuroPharma Announces Last Patient Enrolled In Phase 3 Trial Evaluating INP104 For The Treatment Of Acute Migraine Read more
Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine Read more
Cidara Therapeutics and Mundipharma Form Strategic Partnership to Develop and Commercialize Rezafungin Read more
Vertex to Acquire Semma Therapeutics With a Goal of Developing Curative Cell-Based Treatments for Type 1 Diabetes Read more
An exclusive Aerie Pharmaceuticals speaker interview released for SMi’s Ophthalmic Drugs Conference 2019 Read more
Helsinn signs exclusive distribution and license agreements with Blanver and Varifarma for Pracinostat in South America Read more